Product Information
OLANZAPINE-FLUOXETINE 3-25 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $3.6556 per EA under NDC 00093550356. Its NADAC has been published 626 times since Nov 28, 2013.
FDA first approved this application on Mar 25, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 3 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093550356
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDE; OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA202074FDA Approved
3/25/2013
TE Code
AB
On Market Since
4/10/2013
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE-FLUOXETINE 3-25 MG has been published 626 times since Nov 28, 2013, and over the history we have for it it has declined 49.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6556 per EA |
|---|---|
| All-time high | $8.3904 (Nov 12, 2014) |
| All-time low | $3.1040 (Aug 23, 2023) |
| 52-week high | $3.9971 |
| 52-week low | $3.6556 |
| Median price | $5.2743 |
| Average price | $5.4602 |
| Largest weekly change | +39.1% (Mar 23, 2022) |
| Weeks tracked | 626 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Olanzapine and Fluoxetine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLANZAPINE-FLUOXETINE 3-25 MG?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE-FLUOXETINE 3-25 MG, manufactured by Teva Pharmaceuticals USA Inc., is $3.6556 per EA (NDC 00093550356), effective Aug 19, 2026.
How has the price of OLANZAPINE-FLUOXETINE 3-25 MG changed over time?
Over the history we have for it, the NADAC for OLANZAPINE-FLUOXETINE 3-25 MG has declined 49.4%. It has been tracked across 626 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OLANZAPINE-FLUOXETINE 3-25 MG?
Since Nov 28, 2013, the NADAC for OLANZAPINE-FLUOXETINE 3-25 MG has ranged from a low of $3.1040 (Aug 23, 2023) to a high of $8.3904 (Nov 12, 2014), with a median of $5.2743 per EA.
Are there cheaper alternatives to OLANZAPINE-FLUOXETINE 3-25 MG?
No other NADAC-published product currently shares the active ingredient and strength of OLANZAPINE-FLUOXETINE 3-25 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OLANZAPINE-FLUOXETINE 3-25 MG?
OLANZAPINE-FLUOXETINE 3-25 MG (NDC 00093550356) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.